[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

CY1107001T1 - Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες - Google Patents

Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες

Info

Publication number
CY1107001T1
CY1107001T1 CY20071101459T CY071101459T CY1107001T1 CY 1107001 T1 CY1107001 T1 CY 1107001T1 CY 20071101459 T CY20071101459 T CY 20071101459T CY 071101459 T CY071101459 T CY 071101459T CY 1107001 T1 CY1107001 T1 CY 1107001T1
Authority
CY
Cyprus
Prior art keywords
antique
carboxamide
agents
salt products
nitrogen
Prior art date
Application number
CY20071101459T
Other languages
English (en)
Inventor
Yousuke Furuta
Hiroyuki Egawa
Original Assignee
Toyama Chemical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co., Ltd. filed Critical Toyama Chemical Co., Ltd.
Publication of CY1107001T1 publication Critical patent/CY1107001T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/18—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D253/075—Two hetero atoms, in positions 3 and 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Περιέχοντα άζωτο ετεροκυκλικά παράγωγα καρβοξαμιδίου που παριστάνονται διά του ακόλουθου γενικού τύπου:
CY20071101459T 1998-08-20 2007-11-12 Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες CY1107001T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP25044198 1998-08-20
JP14592299 1999-05-26
EP99938504A EP1112743B1 (en) 1998-08-20 1999-08-18 Nitrogenous heterocyclic carboxamide derivatives or salt thereof as antiviral agents

Publications (1)

Publication Number Publication Date
CY1107001T1 true CY1107001T1 (el) 2012-09-26

Family

ID=26476908

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071101459T CY1107001T1 (el) 1998-08-20 2007-11-12 Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες

Country Status (25)

Country Link
US (2) US6787544B2 (el)
EP (1) EP1112743B1 (el)
JP (1) JP3453362B2 (el)
KR (1) KR100585240B1 (el)
CN (2) CN1275947C (el)
AT (1) ATE376418T1 (el)
AU (1) AU756635B2 (el)
BR (1) BRPI9913097B8 (el)
CA (1) CA2339272C (el)
CY (1) CY1107001T1 (el)
CZ (1) CZ301763B6 (el)
DE (1) DE69937405T2 (el)
DK (1) DK1112743T3 (el)
ES (1) ES2296399T3 (el)
HU (1) HU227475B1 (el)
ID (1) ID28806A (el)
IL (1) IL141150A (el)
MX (1) MXPA01001843A (el)
NO (1) NO321026B1 (el)
NZ (1) NZ509748A (el)
PL (1) PL200955B1 (el)
PT (1) PT1112743E (el)
RU (1) RU2224520C2 (el)
TR (1) TR200100574T2 (el)
WO (1) WO2000010569A1 (el)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60108724T2 (de) 2000-02-16 2005-06-23 Toyama Chemical Co. Ltd. Neue pyrazin-derivate oder salze davon, pharmazeutische zusammensetzungen, die die derivate oder deren salze enthalten und intermediate zu beider herstellung
JP4370164B2 (ja) * 2001-08-14 2009-11-25 富山化学工業株式会社 新規なウイルス増殖阻害・殺ウイルス方法および新規なピラジンヌクレオチド・ピラジンヌクレオシド類似体
PT1441734E (pt) 2001-10-26 2007-05-31 Isti Di Ric Di Bio Moleco P An Di-hidroxipirimidinocarboxamidas inibidoras da integrase do vih
JP3927175B2 (ja) 2001-10-26 2007-06-06 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー Ｎ−置換ヒドロキシピリミジノンカルボキサミド系ｈｉｖインテグラーゼ阻害薬
JP4200758B2 (ja) * 2002-12-26 2008-12-24 株式会社日立ハイテクノロジーズ パネルの樹脂塗布方法、ディスプレイ用パネルの製造方法及び樹脂塗布装置
WO2005049111A2 (en) * 2003-11-13 2005-06-02 Symphony Medical, Inc. Control of cardiac arrhythmias by modification of neuronal conduction within fat pads of the heart
TWI355894B (en) * 2003-12-19 2012-01-11 Du Pont Herbicidal pyrimidines
CN1560035A (zh) * 2004-03-12 2005-01-05 沈阳药科大学 5－羟基吲哚－3－羧酸脂类衍生物
KR100700676B1 (ko) * 2005-06-24 2007-03-28 (주) 비엔씨바이오팜 6―（4―치환된―아닐리노）피리미딘 유도체, 그 제조방법및 이를 포함하는 항바이러스용 약학적 조성물
JP5161078B2 (ja) * 2006-05-31 2013-03-13 富山化学工業株式会社 イノシシ科動物またはヒツジ用抗口蹄疫ウイルス剤およびイノシシ科動物またはヒツジの口蹄疫の予防または治療方法
MX2009008779A (es) * 2007-02-16 2009-11-05 Toyama Chemical Co Ltd Composicion farmacéutica que comprende derivado de pirazina y método para usar el derivado de pirazina en combinación.
CN101289455B (zh) * 2007-04-17 2010-11-10 靳广毅 一种抗流感病毒前体药及其应用
ES2429689T3 (es) 2009-03-13 2013-11-15 Toyama Chemical Co., Ltd. Tableta y polvo granulado que contienen 6-fluoro-3-hidroxi-2-pirazinocarboxamida
JP5739618B2 (ja) * 2009-03-18 2015-06-24 富山化学工業株式会社 ３−ヒドロキシ−２−ピラジンカルボキサミドの製造法
CN103209966B (zh) 2010-09-30 2015-06-10 富山化学工业株式会社 6-氟-3-羟基-2-吡嗪甲酰胺的钠盐
SI2623497T1 (sl) * 2010-09-30 2016-04-29 Toyama Chemical Co., Ltd. Megluminska sol 6-fluoro-3-hidroksi-2-pirazinkarboksamida
TWI486350B (zh) * 2010-11-12 2015-06-01 Fujifilm Corp 吡并［２，３－ｄ］異唑衍生物
CN102846617B (zh) * 2011-07-01 2016-01-13 中国人民解放军军事医学科学院毒物药物研究所 3－(丁基氧基)－2－吡嗪甲酰氨的制备方法和用途
WO2013004092A1 (zh) * 2011-07-01 2013-01-10 中国人民解放军军事医学科学院毒物药物研究所 3-氧代-3，4-二氢-2-吡嗪甲酰氨类衍生物、其药物组合物、其制备方法及用途
CN102617491B (zh) * 2011-07-01 2015-05-06 中国人民解放军军事医学科学院毒物药物研究所 3-氧代-3,4-二氢-2-吡嗪甲酰氨类衍生物、其药物组合物、其制备方法及用途
WO2013004141A1 (zh) * 2011-07-01 2013-01-10 中国人民解放军军事医学科学院毒物药物研究所 3－烷氧基取代－2－吡嗪甲酰氨类化合物及其用途
CN102603657B (zh) * 2011-10-18 2015-02-04 山东齐都药业有限公司 6-溴-3-羟基-2-吡嗪酰胺的制备方法
CN102603658B (zh) * 2011-10-18 2014-04-30 山东齐都药业有限公司 6-氟-3-羟基-2-吡嗪酰胺的制备方法
WO2013161933A1 (ja) * 2012-04-26 2013-10-31 富山化学工業株式会社 重水素化含窒素複素環カルボキサミド誘導体
WO2013180149A1 (ja) * 2012-05-30 2013-12-05 富山化学工業株式会社 重水素化含窒素複素環カルボキサミド誘導体またはその塩
FR3000490B1 (fr) * 2012-12-27 2015-03-13 Anaconda Pharma Procede de synthese d'une hydrazine utile dans le traitement du virus du papillome
US10098879B2 (en) 2015-01-28 2018-10-16 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and pharmaceutical compositions for the treatment of ebola virus disease
CN106588786B (zh) * 2015-10-14 2019-03-08 山东省药学科学院 一种高纯度法匹拉韦杂质的制备方法
CN105687152B (zh) * 2016-03-22 2020-04-07 山东齐都药业有限公司 一种法匹拉韦快速释放药物制剂及制备方法
CN106083745B (zh) * 2016-08-15 2018-08-21 山东百诺医药股份有限公司 6-氟-3-羟基-2-吡嗪酰胺的合成方法
CN107226794A (zh) * 2017-07-17 2017-10-03 郑州大学 一种法匹拉韦的合成方法
BR112020009101A2 (pt) 2017-12-28 2020-10-20 Fujifilm Toyama Chemical Co., Ltd. método para produção de formulação congelada
EP3903783A4 (en) 2018-12-25 2022-03-30 FUJIFILM Toyama Chemical Co., Ltd. THERAPEUTIC AGENT FOR RNA VIRAL INFECTION OBTAINED BY COMBINING A PYRAZINE DERIVATIVE AND A COMPOUND THAT INCREASES THE AMOUNT OF PYRAZINE DERIVATIVE RIBOSE TRIPHOSPHATE BODY IN A CELL
US20230127703A1 (en) 2020-03-30 2023-04-27 Fujifilm Toyama Chemical Co., Ltd. Therapeutic agent for coronavirus infection
US20230218644A1 (en) 2020-04-16 2023-07-13 Som Innovation Biotech, S.A. Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
CN112300083B (zh) * 2020-04-20 2021-08-03 常州制药厂有限公司 一种法匹拉韦的制备方法
CN113563273B (zh) * 2020-04-28 2023-12-26 中国人民解放军军事科学院军事医学研究院 一种抗病毒的吡嗪酰胺衍生物及其制备方法
EP4144353A4 (en) 2020-04-30 2024-08-28 Fujifilm Toyama Chemical Co Ltd CORONAVIRUS INFECTION THERAPEUTICS CONSISTING OF A COMBINATION OF A PYRAZINE DERIVATIVE AND ANOTHER CORONAVIRUS INFECTION THERAPEUTICS
RU2744429C1 (ru) * 2020-05-02 2021-03-09 Андрей Александрович Иващенко Противо-РНК вирусное, в том числе противокоронавирусное средство - замещенный хиноксалин, фармацевтическая композиция и применения
RU2731932C1 (ru) 2020-05-07 2020-09-09 Общество с ограниченной ответственностью "Кромис" (ООО "Кромис") Противо-COVID-19 (SARS-CoV-2) вирусная фармацевтическая композиция
JP7449379B2 (ja) 2020-05-27 2024-03-13 富士フイルム富山化学株式会社 ピラジン誘導体とチオプリン誘導体を組み合わせてなるｒｎａウイルス感染症治療剤
CN111704582B (zh) * 2020-06-23 2021-06-11 杭州煌森生物科技有限公司 一种法匹拉韦及其衍生物的制备方法
JPWO2022131117A1 (el) 2020-12-18 2022-06-23
CN116583269A (zh) 2020-12-18 2023-08-11 富士胶片富山化学株式会社 药物组合物
EP4321163A1 (en) 2021-04-08 2024-02-14 FUJIFILM Toyama Chemical Co., Ltd. Therapeutic agent for coronavirus infection
JPWO2022239823A1 (el) 2021-05-14 2022-11-17
WO2023008530A1 (ja) 2021-07-30 2023-02-02 富士フイルム富山化学株式会社 新型コロナウイルス感染症治療剤

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3472848A (en) * 1966-11-17 1969-10-14 Merck & Co Inc 3-hydroxy and 3-mercapto-pyrazinoyl-guanidines,corresponding ethers and thioethers and processes for their preparation
US3631036A (en) * 1969-11-04 1971-12-28 American Home Prod 5-amino-2 6-substituted-7h-pyrrolo(2 3-d) pyrimidines and related compounds
US3745161A (en) * 1970-04-20 1973-07-10 Merck & Co Inc Phenyl-hydroxy-pyrazine carboxylic acids and derivatives
US4661145A (en) * 1977-03-10 1987-04-28 Rohm And Haas Company Plant growth regulating 1-aryl-1,4-dihydro-4-oxo(thio)-pyridazines
JPS5620576A (en) * 1979-07-27 1981-02-26 Nippon Soda Co Ltd Pyrimidine derivative and selective herbicide
CA1138872A (en) * 1979-07-30 1983-01-04 Rohm And Haas Company Process for the preparation of 1-aryl-1,4- dihydro-4-oxopyridazine-3-carboxamides
US4545810A (en) * 1980-08-07 1985-10-08 Sds Biotech Corporation Herbicidal and plant growth regulant diphenylpyridazinones
US4404203A (en) * 1981-05-14 1983-09-13 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
CA1218655A (en) * 1983-01-28 1987-03-03 Kathleen Biziere Process for the preparation of pyridazine derivatives having a psychotropic action
MX9202022A (es) * 1991-05-01 1992-11-01 Otsuka Pharma Co Ltd Derivados de pirazina y proceso para su preparacion.
FR2705344B1 (fr) 1993-05-17 1995-06-30 Synthelabo Dérivés de 2-aminopyrazine-5-carboxamide, leur préparation et leur application en thérapeutique.
US5597823A (en) * 1995-01-27 1997-01-28 Abbott Laboratories Tricyclic substituted hexahydrobenz [e]isoindole alpha-1 adrenergic antagonists
JPH09216883A (ja) * 1996-02-09 1997-08-19 Fujisawa Pharmaceut Co Ltd ピラゾロピリジン化合物および該化合物を含有する医薬
ATE213495T1 (de) * 1996-09-16 2002-03-15 Du Pont Pharm Co Eine resorbierbare röntgenopake markierung enthaltendes chirurgisches implantat und verfahren zum verriegeln desselben in einem körper

Also Published As

Publication number Publication date
EP1112743A4 (en) 2005-07-06
AU756635B2 (en) 2003-01-16
BRPI9913097B8 (pt) 2021-05-25
KR100585240B1 (ko) 2006-06-01
ES2296399T3 (es) 2008-04-16
NO321026B1 (no) 2006-02-27
DE69937405D1 (de) 2007-12-06
AU5300499A (en) 2000-03-14
BR9913097B1 (pt) 2013-11-12
CN1539828A (zh) 2004-10-27
US6787544B2 (en) 2004-09-07
HUP0103453A3 (en) 2002-11-28
NO20010836L (no) 2001-04-18
CZ301763B6 (cs) 2010-06-16
IL141150A (en) 2005-08-31
HUP0103453A2 (hu) 2002-01-28
CZ2001617A3 (cs) 2001-09-12
CA2339272C (en) 2008-02-05
RU2224520C2 (ru) 2004-02-27
US20020013316A1 (en) 2002-01-31
DK1112743T3 (da) 2007-11-26
BR9913097A (pt) 2001-09-25
HU227475B1 (en) 2011-07-28
TR200100574T2 (tr) 2001-07-23
PT1112743E (pt) 2008-01-14
CA2339272A1 (en) 2000-03-02
KR20010072351A (ko) 2001-07-31
MXPA01001843A (es) 2002-04-08
EP1112743B1 (en) 2007-10-24
CN1154493C (zh) 2004-06-23
DE69937405T2 (de) 2008-02-14
NZ509748A (en) 2003-01-31
JP3453362B2 (ja) 2003-10-06
CN1275947C (zh) 2006-09-20
IL141150A0 (en) 2002-02-10
PL346172A1 (en) 2002-01-28
PL200955B1 (pl) 2009-02-27
CN1313768A (zh) 2001-09-19
ATE376418T1 (de) 2007-11-15
EP1112743A1 (en) 2001-07-04
ID28806A (id) 2001-07-05
WO2000010569A1 (fr) 2000-03-02
USRE43748E1 (en) 2012-10-16
NO20010836D0 (no) 2001-02-19

Similar Documents

Publication Publication Date Title
CY1107001T1 (el) Αζωτουχα ετεροκυκλικα παραγωγα καρβοξαμιδιου ή αλας αυτων ως αντιϊκοι παραγοντες
ATE302775T1 (de) Carbolinderivate
MXPA02011977A (es) Herbicidas de piridina sustituidas.
MA26905A1 (fr) Derives de phenylglycine.
DK0911333T3 (da) Pyrazol [4,3-d]pyrimidinderivater og farmaceutiske præparater, der indeholder disse
NO20005237L (no) Heterocyklisk substituerte amider anvendt som calpain- inhibitorer
TR200200409T2 (tr) Mantar öldürücü heterosiklik aromatik amitler ve bileşimleri, bunları kullanma ve hazırlama yöntemleri.
BG106585A (en) Kinase inhibitors as therapeutic agents
NO20042885L (no) Aryloksyfenyl- og arylsulfanylfenylderivater
RS51444B (sr) JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa
DK1413582T3 (da) Dimere pyrrolobenzodiazepiner
DK0977741T3 (da) Substituerede phenylderivater, deres fremstilling og anvendelse
ATE296826T1 (de) Pyrazolo(1,5)pyridinderivate
EA200501009A1 (ru) Замещённые пирролопиразольные производные в качестве ингибиторов киназы
GB0130341D0 (en) Compounds
ATE346067T1 (de) Carbolinderivate
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
DE60121461D1 (de) Kondensierte pyridoindolderivate
TR200403436T2 (tr) Kristalin 1-metilkarbapenem türevleri.
DE60313350D1 (de) Pyrimidin-2,4-dion-derivate als matrix-metalloproteinase-hemmer
RS53211B (en) PYRIDO [2,3-d] PYRIMIDINE DERIVATIVES, THEIR PRODUCTION, THEIR USE IN THERAPY
DK0640595T3 (da) Substituerede tertiære aminoforbindelser og salte heraf
ES2117264T3 (es) Nuevo compuesto con actividad inhibitoria de la agregacion plaquetaria.
DE60112960D1 (de) Kondensierte pyridoindolderivate